ABUS vs PDD · P/E 5.4, rev $6.2M vs P/E 8.4, rev $61.75B
Arbutus Biopharma Corp (ABUS) versus PDD Holdings Inc. (PDD) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
PDD Holdings Inc. (PDD) is a internet retail company listed on NASDAQ.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported PDD revenue for 2025-12-31 was $61.75B. Net income was $13.99B. Revenue was up 14.5% from 2024-12-31 to 2025-12-31. PDD currently screens at market cap $113.67B and trailing P/E 8.4.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. PDD currently screens at market cap $113.67B and trailing P/E 8.4.
Not investment advice. Open the ABUS and PDD stock pages for the full models.
Not investment advice.